Table 4.
Cancer-related medical visit within the LAST 2 years | |||||
---|---|---|---|---|---|
Yes (N=264) |
No (N=679) |
Univariate Model | |||
Characteristic | % | % | RR | 95% CI | P-value |
Sex | |||||
Female (referent) | 28.7 | 71.3 | 1.0 | ||
Male | 26.1 | 73.9 | 0.9 | 0.7–1.1 | 0.38 |
Current age* | |||||
Mean | 31.1 | 30.0 | 1.1 | 0.9–1.1 | 0.07 |
Race/ethnicity | |||||
Minorities (referent) | 32.0 | 68.0 | 1.0 | ||
White, non-Hispanic | 26.2 | 73.8 | 0.8 | 0.7 – 1.0 | 0.08 |
Health insurance | |||||
No (referent) | 20.2 | 79.8 | 1.0 | ||
Yes | 27.8 | 72.2 | 1.4 | 0.9–2.0 | 0.11 |
Primary care physician | |||||
No (referent) | 17.2 | 82.8 | 1.0 | ||
Yes | 29.1 | 70.9 | 1.7 | 1.1–2.6 | 0.02 |
Education | |||||
≤High school graduate (referent) | 25.8 | 74.2 | 1.0 | ||
Some college or vocational training | 29.1 | 70.9 | 1.1 | 0.9–1.4 | 0.48 |
College graduate | 28.8 | 71.2 | 1.1 | 0.8–1.3 | 0.59 |
Age at cancer diagnosis* | |||||
Mean | 9.5 | 8.6 | 1.1 | 0.9–1.2 | 0.05 |
Interval from diagnosis to survey | |||||
10–14y (referent) | 28.9 | 71.1 | 1.0 | ||
15–19y | 27.0 | 73.0 | 1.0 | 0.8–1.2 | 0.85 |
20–24y | 25.0 | 75.0 | 0.9 | 0.7–1.1 | 0.25 |
≥ 25y | 31.2 | 68.8 | 1.2 | 0.9–1.5 | 0.13 |
Cancer therapy | |||||
Chemotherapy | |||||
Any | 25.4 | 74.6 | 0.8 | 0.6–1.0 | 0.09 |
Alkylating agents, moderate/high dose | 24.7 | 75.3 | 1.1 | 0.8–1.7 | 0.49 |
Anthracyclines≥300 mg/m2 | 32.1 | 67.9 | 1.4 | 1.0–1.9 | 0.03 |
Radiation therapy | |||||
Any | 29.1 | 70.9 | 1.4 | 1.1–1.8 | 0.02 |
Cranial | 27.5 | 72.5 | 1.0 | 0.8–1.3 | 0.74 |
Chest | 32.2 | 67.8 | 1.3 | 1.0–1.6 | 0.06 |
Primary care | |||||
Seen PCP since finishing treatment | 43.4 | 56.6 | 2.2 | 1.8–2.8 | <0.001 |
PCP can handle cancer-related problems | 27.4 | 72.6 | 1.0 | 0.8–1.2 | 0.90 |
Cancer care | |||||
Cancer center visit within last 4yrs | 42.8 | 57.2 | 2.1 | 1.7–2.6 | <0.001 |
Live>200 miles from cancer center | 25.0 | 75.0 | 0.9 | 0.7–1.1 | 0.15 |
Have cancer treatment summary | 38.4 | 61.5 | 1.5 | 1.2 – 2.0 | <0.001 |
Chronic health problem related to cancer | |||||
None/mild (referent) | 18.4 | 81.6 | 1.0 | ||
Moderate/severe/life-threatening | 62.9 | 37.1 | 3.4 | 2.8–4.1 | <0.001 |
Health care motivation† | |||||
Interest in routine medical visit | 3.6 | 3.1 | 1.3 | 1.2–1.4 | <0.001 |
Importance of cancer-related visit | 4.0 | 3.2 | 1.4 | 1.3–1.6 | <0.001 |
Beliefs about health and health care† | |||||
Cancer-related health problem likely | 3.6 | 2.7 | 1.5 | 1.4–1.6 | <0.001 |
Health concerns and worries | 3.0 | 2.5 | 1.6 | 1.4–1.8 | <0.001 |
Confidence in doctors | 3.9 | 3.6 | 1.2 | 1.1–1.3 | 0.01 |
Health locus of control¶ | |||||
Internal | 23.8 | 25.3 | 0.9 | 0.9–0.9 | <0.001 |
Chance | 17.5 | 17.1 | 1.0 | 0.9–1.0 | 0.28 |
Powerful others | 18.8 | 17.5 | 1.1 | 1.0–1.1 | 0.01 |
Influence of survivorship media† | 2.1 | 1.9 | 1.1 | 0.9–1.2 | 0.11 |
Barriers† | |||||
Difficulty finding a doctor | 1.9 | 2.0 | 0.9 | 0.8–1.0 | 0.11 |
Transportation problems§ | 1.4 | 1.3 | 1.4 | 1.0–1.8 | 0.04 |
Health insurance problems | 2.3 | 2.2 | 1.0 | 0.9–1.1 | 0.23 |
Doctors too rushed for questions | 3.4 | 3.3 | 1.1 | 0.9–1.2 | 0.21 |
Painful memory of cancer treatment | 3.8 | 3.4 | 1.2 | 1.1–1.3 | <0.001 |
Notes:
Row percentages and means adjusted for sampling weights and calculated with respect to weighted totals (yes, N=1295; no, N=3446; weighted sum is less than 4903 due to missing values)
RR for each 5-year increase in age
RR for each 1-unit increase on a 5-point Likert scale (1=not at all/almost never; 5=extremely/almost always)
RR for each 1-unit increase on a 36-point scale
RR for moderate/quite a bit/extreme vs. none/a little bit